Status:
COMPLETED
Brain-Computer Interface System for Training Memory and Attention in Elderly
Lead Sponsor:
Duke-NUS Graduate Medical School
Collaborating Sponsors:
Agency for Science, Technology and Research
National University of Singapore
Conditions:
Alzheimer's Disease
Mild Cognitive Impairment
Eligibility:
All Genders
60-80 years
Phase:
PHASE2
Brief Summary
The primary objective is to examine the efficacy of 8-weeks of a locally developed brain-computer interface based system intervention for improving attention and memory in healthy elderly and those wi...
Detailed Description
The world population has reached an unprecedented seven billion, with global population ageing increasing at a greater rate than total population growth. Between 1998 and 2030, the proportion of perso...
Eligibility Criteria
Inclusion
- Age 60-80 years old
- Clinical Dementia Rating (CDR) of 0-0.5
- Mini Mental State Examination (MMSE) of 24 and above
- Geriatric Depression Scale (GDS) of 4 and below
- Chinese Ethnicity
- Literate in English
- Able to travel to study site independently
Exclusion
- Any known neuropsychiatric disorders (such as epilepsy or mental retardation)
- Involvement in another research study (aside from the Singapore Longitudinal Ageing Study)
- Gross hearing, visual or speech impairment that are uncorrected
- Color Blindness
- Intake of the following medications: Rivastigmine, Donepezil, Galantamine or Memantine.
Key Trial Info
Start Date :
July 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT02228187
Start Date
July 1 2015
End Date
June 1 2017
Last Update
August 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke-NUS Medical School
Singapore, Singapore, 169857